
Gabapentin
Gabapentin relieves pain by at least half in about 3 in 10 people with nerve pain after shingles, compared with fewer than 2 in 10 on placebo, and reduces seizures when added to other epilepsy medicines. Its main interactions are alcohol and other sedating products, which deepen drowsiness and can slow breathing, and aluminum or magnesium antacids, which reduce absorption.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with nerve pain after shingles, and adults and children 3 years and older who need an add-on medicine for partial onset seizures, under a prescriber
Common dosing range
Set by a prescriber. For nerve pain after shingles, the Neurontin label starts at 300 mg on day 1 and builds to 900 mg a day by day 3, with a target of up to 1,800 mg a day; for seizures in people 12 and older it starts at 300 mg three times a day. Gralise is built up to 1,800 mg once a day with the evening meal. Lower doses are used when kidney function is reduced, and the Gralise label says Gralise should not be used when creatinine clearance is below 30 mL/min or in people on hemodialysis.
When to expect effects
The Neurontin label reaches 900 mg a day by day 3 for nerve pain; pain trials measured benefit over 4 to 12 weeks
Watch out for
Drowsiness, dizziness and driving impairment; serious or fatal breathing problems when combined with opioids or other sedating medicines, or in people with lung problems; rare severe allergic and multiorgan reactions; and seizures or withdrawal symptoms if stopped suddenly.
What is it
Gabapentin is a prescription anti-seizure medicine that is also used for nerve pain. The Neurontin label approves it for two uses: nerve pain that lingers after shingles (postherpetic neuralgia) in adults, and as an add-on treatment for partial onset seizures in adults and children 3 years and older with epilepsy. It comes as capsules, tablets and an oral solution (Neurontin and many generics), usually taken three times a day. Gralise is a once-daily tablet approved only for postherpetic neuralgia; its label says it cannot be swapped with other gabapentin products. Horizant (gabapentin enacarbil) is a related drug with its own label and is not covered on this page. Gabapentin has no boxed warning, but its label warns about serious breathing problems when it is combined with opioids or other sedating medicines.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
nerve pain after shingles (postherpetic neuralgia) Good Evidence | Moderate; at least 50% pain relief in 32% vs 17% with placebo, number needed to treat 6.7 | Adults with persistent nerve pain after shingles | Measured over 4 to 12 weeks |
add-on treatment for drug-resistant focal (partial) epilepsy Good Evidence | Risk ratio 1.89 for a 50% or greater seizure reduction; 25.3% vs 9.7% response at 1,800 mg a day in adults | People with focal seizures that continue despite other epilepsy medicines | Measured over trials of about 3 months or less |
nerve pain after shingles (postherpetic neuralgia)
- Effect
- Moderate; at least 50% pain relief in 32% vs 17% with placebo, number needed to treat 6.7
- Best fit
- Adults with persistent nerve pain after shingles
- Time
- Measured over 4 to 12 weeks
add-on treatment for drug-resistant focal (partial) epilepsy
- Effect
- Risk ratio 1.89 for a 50% or greater seizure reduction; 25.3% vs 9.7% response at 1,800 mg a day in adults
- Best fit
- People with focal seizures that continue despite other epilepsy medicines
- Time
- Measured over trials of about 3 months or less
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
nerve pain after shingles (postherpetic neuralgia)
Disease adjunctA 2017 Cochrane review of 37 studies with 5,914 adults with nerve pain pooled 8 studies with 2,260 people with postherpetic neuralgia. At 1,200 mg a day or more, 32% had at least 50% pain relief with gabapentin versus 17% with placebo (number needed to treat 6.7), and 46% versus 25% had at least 30% relief (moderate-quality evidence). Across all the nerve pain conditions in the review, dizziness (19%), sleepiness (14%), walking difficulty (14%) and leg swelling (7%) were common with gabapentin. Studies typically lasted 4 to 12 weeks. An earlier 8-week US trial in 229 people, titrated up to 3,600 mg a day, cut average daily pain from 6.3 to 4.2 points on a 0 to 10 scale, compared with 6.5 to 6.0 points on placebo. The review authors note that over half of people treated do not get worthwhile relief but may still have side effects.
Bottom line: About 3 in 10 people with nerve pain after shingles get at least half their pain relieved, versus fewer than 2 in 10 on placebo.
add-on treatment for drug-resistant focal (partial) epilepsy
Disease adjunctA 2021 Cochrane review pooled 6 randomized, double-blind trials with 1,206 people whose focal seizures were not controlled by other medicines. Adding gabapentin made a 50% or greater drop in seizure frequency 1.89 times as likely as placebo (moderate-certainty evidence). In adults, 25.3% responded to 1,800 mg a day compared with 9.7% on placebo. Dizziness and sleepiness were about twice as common, but people did not drop out more often than on placebo. The trials lasted about 3 months or less, so they do not show long-term benefit, and the results do not apply to gabapentin used alone or to other types of epilepsy.
Bottom line: Added to other epilepsy medicines, gabapentin roughly doubles the chance of halving seizure frequency over a few months.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose and adjusts it for kidney function; avoid alcohol, space antacids, and tell your prescriber about every sedating medicine.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Gabapentin has no boxed warning. The label warns that serious, life-threatening or fatal breathing problems (respiratory depression) can occur when gabapentin is used with opioids or other central nervous system depressants, or in people with existing breathing problems.
Drug reaction with eosinophilia and systemic symptoms (DRESS), a multiorgan allergic reaction that has been fatal in some cases; it often starts with fever, rash or swollen glands. Anaphylaxis and angioedema (swelling of the lips, throat and tongue) can occur after the first dose or at any time.
Suicidal thoughts and behavior: anti-seizure medicines, including gabapentin, raise this risk (about twice placebo in a pooled analysis of 199 trials of 11 such drugs), and it has also been reported after stopping gabapentin.
Sleepiness, dizziness and driving impairment: the label says not to drive until you know how gabapentin affects you. Stopping suddenly can raise seizure risk, and withdrawal symptoms (such as anxiety, confusion, sweating, insomnia and seizures) have been reported, usually within 48 hours.
Misuse and abuse have been reported, mostly in people with a history of using several substances; overdose has caused fatal breathing problems, alone and with other sedating drugs.
Who should avoid it
- People who have had an allergic reaction to gabapentin or its ingredients (contraindicated)
- People with reduced kidney function or on hemodialysis, and older adults, need lower doses because the kidneys clear gabapentin; in a label study the half-life rose from about 6.5 hours to 52 hours in people whose creatinine clearance was below 30 mL/min
- People with lung disease or other breathing problems, and people who take opioids or other sedating medicines, need close monitoring and may start at a low dose
- People switching between Gralise and other gabapentin products: the Gralise label says it is not substitutable because it is absorbed and dosed differently. The Gralise label also says Gralise should not be used when creatinine clearance is below 30 mL/min or in people on hemodialysis
Pregnancy & breastfeeding
Pregnancy: the Neurontin label says published cohort studies have not shown an increased risk of major birth defects or miscarriage with gabapentin, but these studies have important limitations; in a US Medicaid study of more than 4,600 first-trimester exposures, the adjusted relative risk of major malformations was 1.07. Animal studies showed harm to developing offspring, so the label says gabapentin may cause fetal harm based on animal data. Extended gabapentin use together with opioids close to delivery may increase the risk of withdrawal in the newborn compared with opioids alone. The label encourages enrolling in the North American Antiepileptic Drug Pregnancy Registry. Breastfeeding: gabapentin passes into breast milk, and its effects on the breastfed infant and on milk production are unknown; the label asks that the benefits of breastfeeding be weighed against the mother's need for the medicine and any possible effects on the infant.
Interactions
Gabapentin and alcohol both slow the brain. The Medication Guide says not to drink alcohol or take other medicines that make you sleepy or dizzy while taking gabapentin without first talking with your healthcare provider, because the combination can make sleepiness or dizziness worse. The label also warns that gabapentin combined with other central nervous system depressants can cause serious, life-threatening breathing problems. Talk to your doctor or pharmacist about any drinking, and seek urgent care for slow or shallow breathing or severe drowsiness.
The label says breathing problems and sedation, sometimes fatal, have been reported when gabapentin is taken with opioids, and morphine raised gabapentin levels by 44% in a small study. In an Ontario study of people taking opioids, also having a gabapentin prescription was linked to higher odds of opioid-related death (adjusted odds ratio 1.49), an association rather than proof of cause. If both are prescribed, the label asks prescribers to watch for drowsiness and slowed breathing and to consider a low gabapentin starting dose.
The label says gabapentin can cause serious breathing problems when used with central nervous system depressants, and asks that people be watched for drowsiness and sedation when gabapentin is combined with other drugs that have sedative properties because the effects may add up. Tell your prescriber and pharmacist about every sedating medicine, including over-the-counter sleep aids.
The Neurontin label says an aluminum and magnesium hydroxide antacid (Maalox) cut gabapentin absorption by about 20%, and by about 10% when gabapentin was taken 2 hours after the antacid; it recommends taking gabapentin at least 2 hours after Maalox. In a crossover study in 13 healthy adults, 1 g of magnesium oxide lowered gabapentin peak levels by 33% and total exposure by 43%, while omeprazole had no effect, which suggests the effect is not about stomach acid. Ask your pharmacist how to time any antacid or magnesium product you use regularly.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (3)
+ alcohol
highGabapentin and alcohol are both central nervous system depressants. Combining them increases drowsiness, dizziness, impaired coordination, and the risk of serious, potentially life-threatening respiratory depression, especially in older adults and people with lung disease, sleep apnea, kidney impairment, or who take opioids or other sedatives.
+ antacids
moderateAn antacid containing aluminum and magnesium hydroxides (Maalox) reduced gabapentin absorption by about 20% when the two were taken together, and by about 10% when gabapentin was taken 2 hours later; the label recommends taking gabapentin at least 2 hours after such an antacid. In a study of 13 healthy adults, 1 g of magnesium oxide lowered gabapentin exposure by 43% while omeprazole had no effect, which suggests the effect is not about stomach acid.
+ magnesium
moderateMagnesium oxide and magnesium antacids taken at the same time as gabapentin reduce how much gabapentin is absorbed. In a crossover study of 13 healthy adults, magnesium oxide lowered gabapentin peak level by 33% and total exposure by 43%, while omeprazole had no effect, and the gabapentin label says a magnesium and aluminum antacid cut absorption by about 20%. Smaller supplement amounts and other magnesium forms, such as citrate or glycinate, have not been tested.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I drink alcohol while taking gabapentin?⌄
The Medication Guide says not to drink alcohol while taking gabapentin without first talking with your healthcare provider, because alcohol can make its sleepiness and dizziness worse. The label also warns that combining gabapentin with other sedating substances can cause serious breathing problems. Ask your doctor or pharmacist what is safe for you.
Can I take an antacid or a magnesium supplement with gabapentin?⌄
Timing matters. An aluminum and magnesium antacid cut gabapentin absorption by about 20%, and the label advises taking gabapentin at least 2 hours after the antacid. In a small study, magnesium oxide lowered gabapentin exposure by 43%. Ask your pharmacist how to space any antacid or magnesium product you take.
Does gabapentin need to be taken with food?⌄
Neurontin and generic gabapentin can be taken with or without food. Gralise is different: its label says to take it with the evening meal, because much less is absorbed on an empty stomach.
Is it safe to take gabapentin with an opioid pain medicine?⌄
The label warns that this combination can cause serious, sometimes fatal, breathing problems and sedation. If both are prescribed, your prescriber should start low and watch for drowsiness and slowed breathing.
Can I stop gabapentin if I feel better?⌄
Not on your own. The label warns that stopping suddenly can raise the risk of seizures and cause withdrawal symptoms such as anxiety, confusion, sweating and insomnia. Talk to your prescriber about a plan.
References by claim
nerve pain after shingles (postherpetic neuralgia)
add-on treatment for drug-resistant focal (partial) epilepsy
Panebianco et al., 2021 · PMC (2021) link
Safety
Interaction: Antacids and magnesium (aluminum and magnesium hydroxide antacids such as Maalox, magnesium oxide)
Yagi et al., 2012 · PubMed (2012) link
Interaction: Opioid pain medicines (morphine, hydrocodone, oxycodone, buprenorphine)
Gomes et al., 2017 · PMC (2017) link
Track Gabapentin with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
